At close: June 14 at 2:51 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-17,885.0000
-29,127.0000
-22,936.0000
-20,476.0000
-8,159.0000
Investing Cash Flow
-35.0000
-82.0000
-530.0000
-367.0000
-174.0000
Financing Cash Flow
15,322.0000
14,782.0000
34,720.0000
8,678.0000
4,993.0000
End Cash Position
535.0000
5,559.0000
19,986.0000
8,732.0000
20,897.0000
Income Tax Paid Supplemental Data
22.0000
19.0000
2.0000
2.0000
2.0000
Capital Expenditure
--
-82.0000
-530.0000
-367.0000
-174.0000
Issuance of Capital Stock
16,403.0000
12,609.0000
29,715.0000
7,949.0000
4,958.0000
Issuance of Debt
2,500.0000
5,000.0000
5,000.0000
715.0000
--
Repayment of Debt
-2,835.0000
-1,800.0000
--
--
--
Free Cash Flow
-17,934.0000
-29,209.0000
-23,466.0000
-20,843.0000
-8,333.0000
12/31/2019 - 8/14/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FRES Fresh2 Group Limited
0.3548
+0.03%
RVPH Reviva Pharmaceuticals Holdings, Inc.
1.4600
-2.67%
ADXS Ayala Pharmaceuticals, Inc.
0.2750
-8.30%
BCEL Atreca, Inc.
0.0900
-1.32%
ATHXQ Athersys, Inc.
0.0040
0.00%
BPTSY Biophytis S.A.
7.59
0.00%
QLGN Qualigen Therapeutics, Inc.
0.1990
+2.10%
ELOX Eloxx Pharmaceuticals, Inc.
0.8000
0.00%
FAMDF Futura Medical plc
0.4800
0.00%
ATHE Alterity Therapeutics Limited
1.8600
-1.59%